Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2026-01-03 @ 11:21 AM
Study NCT ID:
NCT05580692
Status:
TERMINATED
Last Update Posted:
2024-08-19
First Post:
2022-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)
Sponsor:
BioMarin Pharmaceutical
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hemophilia A | View |
Keywords: